share_log

JMP Securities Reiterates Market Outperform on BioAtla, Maintains $12 Price Target

JMP Securities Reiterates Market Outperform on BioAtla, Maintains $12 Price Target

JMP Securities重申BioAtla的市場跑贏大盤,維持12美元的目標股價
Benzinga ·  2023/12/05 09:17

JMP Securities analyst Reni Benjamin reiterates BioAtla (NASDAQ:BCAB) with a Market Outperform and maintains $12 price target.

JMP Securities分析師雷尼·本傑明重申BioAtla(納斯達克股票代碼:BCAB)的股價跑贏大盤,維持12美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論